{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:01Z","timestamp":1793608021531,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030-215041"],"award-info":[{"award-number":["320030-215041"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1GM145886"],"award-info":[{"award-number":["RO1GM145886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61CA297953"],"award-info":[{"award-number":["R61CA297953"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003360","name":"Geneva League Against Cancer","doi-asserted-by":"publisher","award":["2204"],"award-info":[{"award-number":["2204"]}],"id":[{"id":"10.13039\/501100003360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.canlet.2026.218427","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:03Z","timestamp":1773215103000},"page":"218427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and \u03b2-catenin-mutated tumors"],"prefix":"10.1016","volume":"647","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-7525","authenticated-orcid":false,"given":"Monika","family":"Gjorgjieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Correia de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Delangre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-3119","authenticated-orcid":false,"given":"Daniel","family":"Abegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblie","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Adibekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-1433","authenticated-orcid":false,"given":"Pierre","family":"Maechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"7","key":"10.1016\/j.canlet.2026.218427_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/oby.23444","article-title":"Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome","volume":"30","author":"Karra","year":"2022","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102344","article-title":"Cardiovascular-Kidney-Metabolic (CKM) syndrome: a state-of-the-art review","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218427_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib6","first-page":"131","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention","volume":"1","author":"Baffy","year":"2013","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218427_bib7","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218427_bib8","doi-asserted-by":"crossref","first-page":"F375","DOI":"10.1152\/ajprenal.00159.2024","article-title":"ERMP1 as a newly identified endoplasmic reticulum stress gatekeeper in chronic kidney disease","volume":"328","author":"Correia de Sousa","year":"2025","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218427_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1242\/dev.02795","article-title":"Fxna, a novel gene differentially expressed in the rat ovary at the time of folliculogenesis, is required for normal ovarian histogenesis","volume":"134","author":"Garcia-Rudaz","year":"2007","journal-title":"Development"},{"issue":"39","key":"10.1016\/j.canlet.2026.218427_bib10","doi-asserted-by":"crossref","first-page":"63596","DOI":"10.18632\/oncotarget.11550","article-title":"ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer","volume":"7","author":"Grandi","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.canlet.2026.218427_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2019.08.005","article-title":"miR-9-5p attenuates ischemic stroke through targeting ERMP1-mediated endoplasmic reticulum stress","volume":"121","author":"Chi","year":"2019","journal-title":"Acta Histochem."},{"issue":"7","key":"10.1016\/j.canlet.2026.218427_bib12","first-page":"470","article-title":"ERMP1 facilitates the malignant characteristics of colorectal cancer cells through modulating PI3K\/AKT\/\u03b2-Catenin pathway and localization of GRP78","volume":"25","author":"Rahmani-Kukia","year":"2023","journal-title":"Cell J"},{"issue":"3","key":"10.1016\/j.canlet.2026.218427_bib13","article-title":"The pleiotropic enhancer enh9 promotes cell proliferation and migration in non-small cell lung cancer via ERMP1 and PD-L1","volume":"1870","author":"Wang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"12","key":"10.1016\/j.canlet.2026.218427_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.21037\/atm-20-3749","article-title":"miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting endoplasmic reticulum metallo protease 1 to inhibit AKT phosphorylation","volume":"8","author":"Lu","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2014.09.012","article-title":"Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice","volume":"62","author":"Peyrou","year":"2015","journal-title":"J. Hepatol."},{"issue":"19","key":"10.1016\/j.canlet.2026.218427_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194983","article-title":"Mir-21 suppression promotes mouse hepatocarcinogenesis","volume":"13","author":"Correia de Sousa","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.canlet.2026.218427_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune escape and resistance to Anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.canlet.2026.218427_bib18","article-title":"Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver","volume":"7","author":"Gjorgjieva","year":"2025","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218427_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgw118","article-title":"Frequently mutated genes\/pathways and genomic instability as prevention targets in liver cancer","volume":"38","author":"Rao","year":"2017","journal-title":"Carcinogenesis"},{"issue":"7_suppl","key":"10.1016\/j.canlet.2026.218427_bib20","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218427_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10040170","article-title":"Genetic ablation of MiR-22 fosters diet-induced obesity and NAFLD development","volume":"10","author":"Gjorgjieva","year":"2020","journal-title":"J. Personalized Med."},{"issue":"9","key":"10.1016\/j.canlet.2026.218427_bib22","article-title":"Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids","volume":"6","author":"Correia de Sousa","year":"2024","journal-title":"JHEP Rep."},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/SLA.0000000000002904","article-title":"Exercise improves outcomes of surgery on fatty liver in mice: a novel effect mediated by the AMPK pathway","volume":"271","author":"Linecker","year":"2020","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.canlet.2026.218427_bib24","article-title":"Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants","volume":"6","author":"Bril","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.canlet.2026.218427_bib25","article-title":"The role of demethylase AlkB homologs in cancer","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218427_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114607","article-title":"Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma","volume":"378","author":"Chen","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218427_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101452","article-title":"Disrupted liver oxidative metabolism in glycine N-methyltransferase-deficient mice is mitigated by dietary methionine restriction","volume":"58","author":"Rome","year":"2022","journal-title":"Mol. Metabol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218427_bib28","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-10-2705","article-title":"Coactivation of AKT and \u03b2-catenin in mice rapidly induces formation of lipogenic liver tumors","volume":"71","author":"Stauffer","year":"2011","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2026.218427_bib29","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","article-title":"Specific features of \u00df-catenin-mutated hepatocellular carcinomas","volume":"131","author":"Dantzer","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","article-title":"\u03b2-catenin-activated hepatocellular carcinomas are addicted to fatty acids","volume":"68","author":"Senni","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.gendis.2023.02.050","article-title":"WNT\/\u03b2-catenin signaling in hepatocellular carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities","volume":"11","author":"Gajos-Michniewicz","year":"2024","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.canlet.2026.218427_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyo\u011flu","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.canlet.2026.218427_bib33","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ijc.28798","article-title":"Ha-ras and \u03b2-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors","volume":"135","author":"Unterberger","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218427_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1947601911409738","article-title":"The role of p53 in metabolic regulation","volume":"2","author":"Puzio-Kuter","year":"2011","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218427_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/msp2.70015","article-title":"Immune infiltration in TP53 missense mutant contributes to poor prognosis in hepatocellular carcinoma, unlike CTNNB1 mutations","volume":"2","author":"Veeraiyan","year":"2025","journal-title":"Malign. Spectrum"},{"issue":"1","key":"10.1016\/j.canlet.2026.218427_bib36","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1038\/s41598-024-58587-6","article-title":"Proteomic analysis of DEN and CCl(4)-induced hepatocellular carcinoma mouse model","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.canlet.2026.218427_bib37","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ng1481","article-title":"Application of comparative functional genomics to identify best-fit mouse models to study human cancer","volume":"36","author":"Lee","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218427_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2164-15-99","article-title":"The effect of dietary fat intake on hepatic gene expression in LG\/J AND SM\/J mice","volume":"15","author":"Partridge","year":"2014","journal-title":"BMC Genom."},{"key":"10.1016\/j.canlet.2026.218427_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05607","article-title":"The genetic architecture of NAFLD among inbred strains of mice","volume":"4","author":"Hui","year":"2015","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172000","article-title":"Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor","volume":"12","author":"Lede","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.canlet.2026.218427_bib41","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10439-009-9738-6","article-title":"A model of NEFA dynamics with focus on the postprandial state","volume":"37","author":"Jelic","year":"2009","journal-title":"Ann. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.canlet.2026.218427_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166956","article-title":"Role of PTEN in oxidative stress and DNA damage in the liver of whole-body pten haplodeficient mice","volume":"11","author":"Bankoglu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218427_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/JHC.S450460","article-title":"Advances in the pathogenesis of metabolic liver disease-related hepatocellular carcinoma","volume":"11","author":"Chen","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.canlet.2026.218427_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101414","article-title":"Inflammation in MASLD progression and cancer","author":"Kim","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.canlet.2026.218427_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102643","article-title":"Mitochondrial cholesterol: metabolism and impact on redox biology and disease","volume":"61","author":"Goicoechea","year":"2023","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218427_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071898","article-title":"Farnesoid X receptor activation enhances transforming growth factor \u03b2-Induced epithelial-mesenchymal transition in hepatocellular carcinoma cells","volume":"19","author":"Kainuma","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"437","key":"10.1016\/j.canlet.2026.218427_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target","volume":"10","author":"Liu","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"61","key":"10.1016\/j.canlet.2026.218427_bib48","doi-asserted-by":"crossref","first-page":"104136","DOI":"10.18632\/oncotarget.22024","article-title":"Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis","volume":"8","author":"Enr\u00edquez-Cortina","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.canlet.2026.218427_bib49","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/ijc.33885","article-title":"Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma","volume":"150","author":"Stepien","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218427_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13073-022-01071-5","article-title":"Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease","volume":"14","author":"Assante","year":"2022","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218427_bib51","first-page":"144","article-title":"Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma","volume":"21","author":"Song","year":"2023","journal-title":"Cancer Biol. Med."},{"issue":"3","key":"10.1016\/j.canlet.2026.218427_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3727\/105221615X14181438356292","article-title":"Role of hepatocyte nuclear factor 4\u03b1 (HNF4\u03b1) in cell proliferation and cancer","volume":"16","author":"Walesky","year":"2015","journal-title":"Gene Expr."},{"key":"10.1016\/j.canlet.2026.218427_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55865","article-title":"Inhibiting IRE1\u03b1-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma","volume":"9","author":"Pavlovi\u0107","year":"2020","journal-title":"eLife"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:37:06Z","timestamp":1793605026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"alternative-id":["S0304383526001904"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218427","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and \u03b2-catenin-mutated tumors","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218427"}}